相关实验视频
Updated: Jan 10, 2026

13:58
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Published on: October 22, 2012
18.6K
在MPER/脂质体疫苗中,异种免疫调节了辅助和MPER部分之间的B细胞表位竞争
bioRxiv : the preprint server for biology
|November 24, 2025
概括
异质增强通过改善B细胞亲和力和减少竞争来增强对HIV-1保存的MPER区域的免疫反应. 这一策略对于开发针对HIV-1等可变病毒的广泛中和抗体 (bnAbs) 至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 亚主导B细胞对保存表位体的反应,如HIV-1 gp41 MPER,阻碍了广泛中和抗体 (bnAb) 的发展.
- 该MPER在HIV-1病毒上被部分封闭,限制了B细胞的可访问性和反应.
- 疫苗策略必须克服这些挑战,以获得有效的bnAbs来对抗可变病毒.
研究的目的:
- 评估基于脂质体的MPER疫苗策略与T细胞辅助表位组结合.
- 研究异质增强对MPER特异性B细胞反应和抗体功能的影响.
- 了解如何启动抗原和辅助的联合递送塑造免疫反应.
主要方法:
- 开发了一种具有单个CD4 T细胞辅助表位的MPER/脂质体疫苗.
- 施用了初始原始化,随后进行异质增强.
- 分析了B细胞反应,抗体亲和力和疫苗接种后的功能.
主要成果:
- 化引发了低亲和度的MPER特异性B细胞,反应受到主导辅助表位的影响.
- 异质增强显著增强MPER特异性B细胞扩张和血抗体功能.
- 增加MPER B细胞亲和力,减少辅助表位特异性B细胞的竞争.
结论:
- 异质增强是一种可行的策略,可以增强亚主导B细胞对保存的病毒表位的反应.
- 启动抗原对随后的MPER抗体反应的结果具有重要影响.
- 这种方法为设计针对HIV-1等频繁变异的病毒的疫苗提供了洞察力.
相关概念视频
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Cross-reactivity
32.8K
Overview
32.8K
B Cell Activation and Differentiation
15.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.8K
Hybridoma Technology
17.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.2K
Diversity of Antigen Receptors
1.4K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.4K

